open access

Vol 77, No 6 (2009)
ORIGINAL PAPERS
Published online: 2009-11-30
Submitted: 2013-02-22
Get Citation

Outpatients specialist care of chronic obstructive pulmonary disease patients in Poland - results of the KOMPAS study

Filip Mejza, Ewa Niżankowska-Mogilnicka, Ryszard Kurzawa, Paweł Górski, Bernard Wirkijowski, Roman Jaeschke
Pneumonol Alergol Pol 2009;77(6):507-516.

open access

Vol 77, No 6 (2009)
ORIGINAL PAPERS
Published online: 2009-11-30
Submitted: 2013-02-22

Abstract


Introduction: COPD is one of the most important lung diseases. It is responsible for significant proportion of outpatients pulmonary clinics visits. Data on outpatients care of COPD patients in Poland are limited. This article presents design of the KOMPAS study and basic results relating to COPD patients.
Material and methods: The aim of this prospective study was to describe population of patients with COPD treated by specialists, and to characterize methods of care used in various COPD stages. Participating physicians used pocket PCs equipped with specially developed software to collect COPD patients’ data.
Results: Data on 2958 COPD patients were analyzed. 2/3 of patients were males. Mean patients age was 63 years and mean FEV1 - 57% of predicted value. 86% of all subjects underwent spirometry during the first visit or the previous 6 months. Cough and exertional dyspnoea were the most frequently reported COPD symptoms (about 80% of patients). At the first visit 32% of subjects were current smokers and 51% were ex-smokers. 17% of all study patients have never smoked. Before inclusion 2/3 of patients were treated with bronchodilatator, and about 1/3 with inhaled steroid. After entering the study, over 90% received bronchodilatator and more than 2/3 received inhaled steroid. Differences in treatment between stages of COPD based on its severity were relatively small.
Conclusions: Results of the KOMPAS study provide basic information about COPD outpatients care in Poland. These data, especially concerning physicians’ compliance with current COPD guidelines, may be useful in planning undergraduate/postgraduate training for physicians and for those who are responsible for health resource allocation.

Abstract


Introduction: COPD is one of the most important lung diseases. It is responsible for significant proportion of outpatients pulmonary clinics visits. Data on outpatients care of COPD patients in Poland are limited. This article presents design of the KOMPAS study and basic results relating to COPD patients.
Material and methods: The aim of this prospective study was to describe population of patients with COPD treated by specialists, and to characterize methods of care used in various COPD stages. Participating physicians used pocket PCs equipped with specially developed software to collect COPD patients’ data.
Results: Data on 2958 COPD patients were analyzed. 2/3 of patients were males. Mean patients age was 63 years and mean FEV1 - 57% of predicted value. 86% of all subjects underwent spirometry during the first visit or the previous 6 months. Cough and exertional dyspnoea were the most frequently reported COPD symptoms (about 80% of patients). At the first visit 32% of subjects were current smokers and 51% were ex-smokers. 17% of all study patients have never smoked. Before inclusion 2/3 of patients were treated with bronchodilatator, and about 1/3 with inhaled steroid. After entering the study, over 90% received bronchodilatator and more than 2/3 received inhaled steroid. Differences in treatment between stages of COPD based on its severity were relatively small.
Conclusions: Results of the KOMPAS study provide basic information about COPD outpatients care in Poland. These data, especially concerning physicians’ compliance with current COPD guidelines, may be useful in planning undergraduate/postgraduate training for physicians and for those who are responsible for health resource allocation.
Get Citation

Keywords

chronic obstructive pulmonary disease; outpatients care; KOMPAS study

About this article
Title

Outpatients specialist care of chronic obstructive pulmonary disease patients in Poland - results of the KOMPAS study

Journal

Advances in Respiratory Medicine

Issue

Vol 77, No 6 (2009)

Pages

507-516

Published online

2009-11-30

Bibliographic record

Pneumonol Alergol Pol 2009;77(6):507-516.

Keywords

chronic obstructive pulmonary disease
outpatients care
KOMPAS study

Authors

Filip Mejza
Ewa Niżankowska-Mogilnicka
Ryszard Kurzawa
Paweł Górski
Bernard Wirkijowski
Roman Jaeschke

References (22)
  1. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J. 2006; 27(1): 188–207.
  2. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004; 364(9434): 613–620.
  3. European ReE, Gibson GJ, Sibille Y. European Respiratory Society/European Lung Foundation.. Chronic obstructive pulmonary disease. In: Loddenkemper R, Gibson GJ, Sibille Y. ed. European Lung White Book — the First Comprehensive Survey on Respiratory Health in Europe. ERSJ, Sheffield 2003: 34–43.
  4. Nizankowska-Mogilnicka E, Mejza F, et al. Buist A.S. Częstość występowania POChP i rozpowszechnienie palenia tytoniu w Małopolsce — wyniki badania BOLD w sce. Pol Arch Med Wewn. 2007; 117: 402–409.
  5. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007; 370(9589): 765–773.
  6. Ramsey SD, Sullivan SD, Sullivan SD, et al. The economic burden of COPD. Chest. 2000; 117(2 Suppl): 5S–9S.
  7. Feenstra TL, van Genugten ML, Hoogenveen RT, et al. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med. 2001; 164(4): 590–596.
  8. Rozpoznawanie i leczenie przewlekłej obturacyjnej choroby płuc. Wytyczne Światowej Inicjatywy Zwalczania Przewlekłej Obturacyjnej Choroby Płuc (GOLD 2006). Med Prakt. 2007; 2: 77–102.
  9. Zalecenia skiego Towarzystwa Ftyzjopneumonologicznego rozpoznawania i leczenia przewlekłej obturacyjnej choroby płuc (POChP). Pneumonol Alergol Pol. 2004; 72(supl. 1).
  10. Bassand JP, Priori S, Tendera M. Evidence-based vs. 'impressionist' medicine: how best to implement guidelines. Eur Heart J. 2005; 26(12): 1155–1158.
  11. http://www.stat.gov.pl/cps/rde/xbcr/gus/PUBL_stan_zdrowia_2004.pdf (07.10.2007).
  12. Słomiński JM, Gorzewska A, Pacek M, et al. [Assessment of drug therapy in chronic pulmonary obstructive disease]. Pol Merkur Lekarski. 2004; 16(92): 133–136.
  13. Zieliński J, Kuca P, Ptasznik P, et al. Rozpoznawanie i leczenie POChP przez lekarzy specjalistów — zgodność z zaleceniami. Pneumonol Alergol Pol. 2005; 73: 135–141.
  14. Tsagaraki V, Markantonis SL, Amfilochiou A. Pharmacotherapeutic management of COPD patients in Greece--adherence to international guidelines. J Clin Pharm Ther. 2006; 31(4): 369–374.
  15. Fritsch K, Jacot ML, Klarer A, et al. Adherence to the Swiss guidelines for management of COPD: experience of a Swiss teaching hospital. Swiss Med Wkly. 2005; 135(7-8): 116–121.
  16. Decramer M, Bartsch P, Pauwels R, et al. Management of COPD according to guidelines. A national survey among Belgian physicians. Monaldi Arch Chest Dis. 2003; 59(1): 62–80.
  17. http://www.stat.gov.pl/cps/rde/xbcr/gus/PUBL_ochrona_zdrowia_2005.pdf (07.10.2007).
  18. Buist AS, McBurnie MA, Vollmer WM, et al. BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007; 370(9589): 741–750.
  19. Sichletidis L, Chloros D, Spyratos D, et al. The validity of the diagnosis of chronic obstructive pulmonary disease in general practice. Prim Care Respir J. 2007; 16(2): 82–88.
  20. Walker PP, Mitchell P, Diamantea F, et al. Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J. 2006; 28(5): 945–952.
  21. Sichletidis L, Chloros D, Spyratos D, et al. The validity of the diagnosis of chronic obstructive pulmonary disease in general practice. Prim Care Respir J. 2007; 16(2): 82–88.
  22. Walker PP, Mitchell P, Diamantea F, et al. Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J. 2006; 28(5): 945–952.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl